Over recent years, genome-wide association studies have contributed to our understanding of genetic susceptibility to sporadic cancer. In this study, we assessed the association between upper gastrointestinal cancer risk and four genome-wide association studies-identified single nucleotide polymorphisms (SNPs), implicated earlier in prostate and colorectal cancer susceptibility. Genotyping for each SNP was performed in two independent Caucasian population-based case-control studies. The first study comprised 290 gastric cancer cases and 374 controls. The second study included 185 noncardia gastric cancers, 123 cardia cancers, 158 oesophageal cancers and 209 controls. Odds ratios (ORs) were computed from logistic models and adjusted for potential confounding variables. An inverse association was observed between the SNP rs1447295, located at 8q24, and gastric cancer risk in the first study population (OR = 0.63; 95% confidence interval: 0.41-0.97). A positive association was observed for the same SNP and oesophageal squamous cell carcinoma in the second study population (OR = 7.43; 95% confidence interval: 1.37-49.98). No significant associations were detected in either study for the three remaining SNPs (rs6983297, rs10505477 and rs719725).
Introduction
Gastric and oesophageal cancers represent important global causes of cancer-related mortality and contribute to a significant burden of disease, particularly in economically lesser-developed countries (Ferlay et al., 2010) . The prognosis for individuals diagnosed with these tumours is usually bleak, with a poor overall survival statistics even in developed countries (Crane et al., 2008; Bouvier et al., 2010) .
Several genome-wide association studies have shown associations between markers in the gene-poor region, 8q24, and the risk for a variety of solid tumours (Ghoussaini et al., 2008; Kiemeney et al., 2008; Park et al., 2008; Wokolorczyk et al., 2008) , most notably prostate cancer (Amundadottir et al., 2006; Gudmundsson et al., 2007; Zheng et al., 2007; Yeager et al., 2009) . The 8q24 prostate cancer-associated single nucleotide polymorphisms (SNPs) include rs6983267 and rs1447295; these two SNPS are jointly estimated to account for approximately one-quarter of the population-attributable risk in Caucasian men (Yeager et al., 2007; Zheng et al., 2008) . In 2007, several independent groups identified variants at 8q24, which were associated with increased risk of sporadic colorectal cancer, including rs10505477 (Haiman et al., 2007; Tomlinson et al., 2007; Zanke et al., 2007) . In addition, one of these groups identified a colorectal cancer-associated SNP at 9p24 (Zanke et al., 2007) that was robustly validated later in the Colon Cancer Family Registry (Poynter et al., 2007) . The influence of genetic polymorphisms at 8q24 and 9p24 on upper gastrointestinal cancer susceptibility has not been assessed yet. We therefore carried out a genotyping study to assess the associations between four of the earlier described prostate or colorectal cancer-associated SNPs in these regions, and risk of upper gastrointestinal cancer.
Materials and methods

Study populations
Genotyping of all four SNPs was performed in two independent Caucasian population-based case-control studies of upper gastrointestinal cancer. The influence of lifestyle factors such as smoking, diet and alcohol consumption on upper gastrointestinal cancer risk in these two studies has been extensively investigated earlier (Gammon et al., 1997; Chow et al., 1999; Engel et al., 2002; Lissowska et al., 2004; Krstev et al., 2005) .
The first study was a gastric cancer case-control study derived from a Polish population. Cases were residents of Warsaw who had been newly diagnosed with gastric cancer at one of 22 hospitals serving the study area. Controls were randomly selected from an Electronic Residency Registry and frequency-matched by age and sex (Chow et al., 1999) . DNA samples were available from 290 gastric cancer cases and 374 control individuals. The second study was a multicentre oesophageal and gastric cancer study conducted in three distinct geographical regions of the United States holding population-based cancer registries (Gammon et al., 1997) . Cases were residents of the three study regions who had been newly diagnosed with gastric or oesophageal cancer. Population-based controls were identified by random digit dialling or random sampling of Health Care Financing Administration rosters, and were frequency-matched by age and sex. DNA samples were available from a total of 308 patients with gastric cancer (122 cardia and 184 noncardia, 90% Caucasian), 158 oesophageal cancer cases (51 squamous cell and 107 adenocarcinoma, 90% Caucasian) and 209 matched population controls (94% Caucasian). The institutional review boards of the participating centres approved the study and written informed consent was obtained from all individuals.
Genotype assays
Genotyping for the four SNPs (rs6983267, rs10505477, rs1447295 and rs719725) was performed by real-time PCR using predesigned Taqman assays with minor groove binding probes 5 0 -labelled with FAM or VIC fluorophores to detect the common and variant alleles (PE Applied Biosystems, Foster City, California, USA; Livak, 1999) . Genotyping calls were possible in over 97% of samples using the StepOneplus allelic discrimination system (Applied Biosystems).
Statistical analyses
Hardy-Weinberg equilibrium (HWE) of alleles at the four polymorphic loci were assessed using w 2 statistics. Odds ratios (OR) with Cornfield 95% confidence intervals (CIs) were computed using logistic regression using STATA version 7.0 software (STATA Press, College Station, Texas, USA). Models were run to adjust for age, sex and (in the US study only) race.
Results
For rs6983267, rs10505477 and rs719725, allele frequencies in both the study control populations were in HWE with nonsignificant w 2 values. For rs1447295, there was a heterozygote deficit in the Polish control population (w 2 = 7.43, P = 0.006); however, allele frequencies were in HWE for the US study controls. For all four polymorphisms, minor allele frequencies were similar to those reported earlier for Caucasians. Adjustment for age, sex and race made no material difference to the crude ORs.
No associations were found between rs6983267, rs10505477 or rs719725 and upper gastrointestinal cancer risk.
For the rs1447295 (A > C) polymorphism, an inverse association was observed between carriage of the minor allele (A) and the risk of gastric cancer in the Polish study population (Table 1) . This was apparent only in a dominant model, giving an OR of 0.63 (95% CI: 0.41-0.97). No similar association was seen either for gastric cardia or for noncardia cancer in the US study population (data not shown), where homozygosity for the A allele yielded an OR of 7.04 (95% CI: 1.29-46.63) for oesophageal squamous cell carcinoma (Table 2) . A similar OR was observed in a recessive model. No association was observed between rs1447295 and oesophageal adenocarcinoma (data not shown). Although the observed inverse association with gastric cancer, only apparent in the Polish study, may reflect a population-specific effect, as has been described for other gastric cancer-associated polymorphisms (Ohyauchi et al., 2005; Canedo et al., 2008) , larger case-control series would be required to address this possibility. Interestingly, a recent publication reported that rs1447285 was not associated with common solid tumours, other than prostate cancer, in a Polish population (Wokolorczyk et al., 2010) . This large case-control study did not, however, include any upper gastrointestinal cancer cases.
The finding of opposing risk effects of an SNP on different cancers at different anatomic sites is not novel. In addition to being a risk factor for prostate and colorectal cancers, rs6983267 appears to confer a protective effect in the risk of bladder cancer (Park et al., 2008) .
The mechanism by which 8q24 SNPs, located in a nonproteincoding genomic region, modify cancer risk is not fully understood. Several hypotheses have been put forward including the suggestion that 8q24 harbours cisregulatory enhancers for the nearby MYC proto-oncogene.
There is now mounting evidence to support an interaction between 8q24 loci and MYC. Tuupanen et al. (2009) have shown that rs6982367 lies within a functional enhancer, and that the risk genotype leads to enhanced binding of the Wnt-regulated transcription factor 4 (TCF4). Data from Pomerantz et al. (2009) suggest that TCF4 not only binds to a transcriptional enhancer at the rs6983267 locus, but that the risk region physically interacts with MYC. This interaction is supported by data from a recent publication, which suggest that the formation of longrange chromatin loops with MYC is a tissue-specific mechanism, common to the prostate, colon and breast cancer-associated 8q24 loci (Ahmadiyeh et al., 2010) .
This hypothesis-testing study has a number of limitations. Although only a small number of comparisons were made in this study, we cannot exclude the significant findings that may, through multiple testing, have arisen by chance. We acknowledge the possibility that violation of HWE for rs1447295 in the Polish controls could result in bias. In addition, the number of oesophageal cancer cases in the US study is small, potentially leading to an over or underestimation of the magnitude of the observed association. We feel that the findings of the study are, however, important enough to justify validation in the additional case-control series. Furthermore, the influence of rs1447295 on the risk of solid tumours other than prostate cancer warrants further investigation.
A comprehensive knowledge of the genetic contribution to upper gastrointestinal cancer risk has the potential to facilitate the development of risk stratification models that could assist screening decisions in high-risk populations. Germline genetic polymorphisms are emerging as biomarkers of cancer prognosis and response to treatment, and could help inform clinical decision making in personalized cancer therapy (Roukos et al., 2007; Coate et al., 2010) .
In conclusion, our data represent novel findings on heritable gastric and oesophageal cancer risk, which merit validation in additional populations. The emerging data on the functionality of 8q24 cancer-associated SNPs will hopefully enhance our understanding of the molecular pathology of upper gastrointestinal cancers.
